Cancer Patients Clinical Trials

8 recruiting

Cancer Patients Trials at a Glance

77 actively recruiting trials for cancer patients are listed on ClinicalTrialsFinder across 6 cities in 24 countries. The largest study group is Not Applicable with 26 trials, with the heaviest enrollment activity in New York, Shanghai, and Myrtle Beach. Lead sponsors running cancer patients studies include Memorial Sloan Kettering Cancer Center, Henan Cancer Hospital, and Fudan University.

Browse cancer patients trials by phase

Treatments under study

About Cancer Patients Clinical Trials

Looking for clinical trials for Cancer Patients? There are currently 8 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Cancer Patients trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Cancer Patients clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 77 trials

Recruiting
Phase 3

Neoadjuvant Radiotherapy for Rectal Adenocarcinoma With Capecitabine Versus TAS-102 (Neo-REACT): A Multi-center, Randomized, Phase III Trial

Rectal CancerRectal Cancer Patients
Shandong Cancer Hospital and Institute210 enrolled1 locationNCT06850090
Recruiting
Phase 2

Radiotherapy Plus Iparomlimab and Tuvonralimab (QL1706), Regorafenib, and CAPOX as Neoadjuvant Therapy for pMMR/MSS LARC.

Rectal Cancer Patients
Sun Yat-sen University88 enrolled1 locationNCT06911684
Recruiting

Impact of ICCAN on Cancer Treatment Completion and Quality of Life

Cancer Patients
Memorial Sloan Kettering Cancer Center347 enrolled11 locationsNCT01742143
Recruiting
Not Applicable

Prevention of CIPN Using Compressive Therapy

CIPN in Adjuvant Breast Cancer Patients
Martina Lojova100 enrolled1 locationNCT06823440
Recruiting
Not Applicable

Cancer Survivors Program

Breast Cancer PatientsProstate Cancer Patients
Masaryk Memorial Cancer Institute200 enrolled1 locationNCT07253987
Recruiting
Phase 2

Pinoxin for the Prevention of Radiation-Induced Skin Injury

Cancer Patients Undergoning Radiotherapy
Fudan University202 enrolled2 locationsNCT07545720
Recruiting
Not Applicable

Mindfulness-Oriented Respiratory Distress Symptom Intervention for Lung Cancer

Symptom ClusterBreathlessnessCoughing+3 more
The Hong Kong Polytechnic University64 enrolled1 locationNCT07281300
Recruiting

Study of the Epidemiological, Clinical, Diagnostic, and Therapeutic Characteristics of Prostate Cancers in Algeria

Prostate CancerProstate Cancer MetastaticProstate Cancer (Adenocarcinoma)+3 more
Société Algérienne de Formation et Recherche en Oncologie2,000 enrolled24 locationsNCT07484971
Recruiting
Not Applicable

The Effect of Cold Salt Water Foot Bath on the Development Of Chemotherapy-Induced Peripheral Neuropathy

Breast Cancer Patients
Tuba Eryiğit30 enrolled1 locationNCT06964802
Recruiting
Phase 3

64Cu-SAR-bisPSMA Positron Emission Tomography: A Phase 3 Study of Participants With Biochemical Recurrence of Prostate Cancer

Prostate CancerCryotherapyProstate Cancer Recurrent+3 more
Clarity Pharmaceuticals Ltd220 enrolled28 locationsNCT06970847
Recruiting
Phase 1

TSL2109 Capsules in Advanced Solid Tumor Patients: Safety, Tolerability, PK and Preliminary Efficacy

Metastatic Castration-Resistant Prostate Cancer Patients
Tasly Pharmaceutical Group Co., Ltd78 enrolled1 locationNCT07514065
Recruiting
Not Applicable

Writing Intervention With Adolescents and Young Adults With Cancer

Cancer PatientsCommunication Research
St. Jude Children's Research Hospital26 enrolled1 locationNCT05975333
Recruiting

Real World Pediatric Oncology Rehabilitation in Italy ( ReWori )

Pediatric CancerRehabilitationPhysical Therapy+3 more
Associazione Italiana Ematologia Oncologia Pediatrica249 enrolled13 locationsNCT07368582
Recruiting
Phase 1

A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)

Metastatic Castration-resistant Prostate CancerMetastatic Castration-Resistant Prostate Cancer Patients
K36 Therapeutics, Inc.144 enrolled13 locationsNCT07103018
Recruiting
Phase 2

A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec

Prostate Cancer (Adenocarcinoma)Prostate Cancer Patients Treated by Radiotherapy
Candel Therapeutics, Inc.45 enrolled7 locationsNCT07332000
Recruiting

SpaceOAR Post-Market Registry Study

Prostate Cancer Patients Treated by Radiotherapy
Sheffield Teaching Hospitals NHS Foundation Trust320 enrolled8 locationsNCT07300631
Recruiting
Not Applicable

Two-fraction Proton Therapy With MRI Guidance for Prostate Cancer: A Phase II Trial

Prostate Cancer Patients Treated by Radiotherapy
Hong Kong Sanatorium & Hospital35 enrolled1 locationNCT07130682
Recruiting
Phase 1

Trial of pTVG-HP+Nivo+Targeted Ablation of Resistant Lesions in Non-Castrate RecurrentOMPC

Prostate Cancer PatientsRecurrent Prostate CancerOligometastatic Prostate Cancer (OMPC)+1 more
University of Wisconsin, Madison14 enrolled1 locationNCT07090148
Recruiting
Phase 2

Neoadjuvant Chemotherapy and PD-1 Inhibitor for Locally Advanced Rectal Cancer(CONTROL-01)

Rectal Cancer Patients
The Affiliated Hospital of Qingdao University35 enrolled1 locationNCT06647680
Recruiting
Not Applicable

A Study of an Anxiety Intervention for Latino/Latina/Hispanic Older Adults With Cancer and Their Caregivers

Cancer PatientsCare Givers
Memorial Sloan Kettering Cancer Center60 enrolled7 locationsNCT06305741